New insider activity at Procter & Gamble ( (PG) ) has taken place on August 21, 2025.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Jennifer L. Davis, the CEO of Health Care at Procter & Gamble, recently sold 8,596 shares of the company’s stock, amounting to a total transaction value of $1,351,892.
Spark’s Take on PG Stock
According to Spark, TipRanks’ AI Analyst, PG is a Outperform.
Procter & Gamble’s overall stock score reflects its strong financial performance and stable earnings outlook, despite technical resistance and macroeconomic challenges. The company’s strategic focus on innovation and shareholder returns supports its market position.
To see Spark’s full report on PG stock, click here.
More about Procter & Gamble
YTD Price Performance: -3.02%
Average Trading Volume: 8,150,069
Technical Sentiment Signal: Buy
Current Market Cap: $371B